Assessment and management of bipolar disorder: summary of updated NICE guidance
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Bipolar disorder is a complex, recurrent, and severe mental illness that has an onset typically between 13 and 30 years of age and a lifetime prevalence of 1.4%.1 It is characterised by episodes of mania or hypomania with elation, overactivity, and disinhibited behaviour, as well as episodes of depression with profound loss of interest and motivation, often with milder depressed mood in between episodes. Bipolar disorder is associated with an increased risk of suicide and physical illness, such as ischaemic heart disease, diabetes, chronic obstructive airways disease, pneumonia, and unintentional injury.2 Around two thirds of people with bipolar disorder also experience another mental disorder, usually anxiety disorders, substance misuse disorders, or impulse control disorders.1 The risk of recurrence in the year after a mood episode is especially high (50% in one year and >70% at four years) compared with other psychiatric disorders,3 and this has important implications for the long term management of the disorder. This article summarises the most recent recommendations from the National Institute for Health and Care Excellence (NICE) on assessing and managing bipolar disorder in adults, children, and young people.4 NICE recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. ### Care for adults, children, and young people across all phases of bipolar disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Comorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“…depressive phase of BD should be managed in a comprehensive biopsychosocial manner (Berk et al., 2013; Malhi et al., 2012b), and adjunctive structured psychological interventions should be offered to help stabilise depressive episodes (Goodwin, 2009; Kendall et al., 2014; Yatham et al., 2013b).”
BackgroundLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., & Dickersin, K. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.007 · Cited by 131
“We examined two commonly prescribed drugs recommended in clinical practice guidelines, gabapentin for neuropathic pain [28] and quetiapine for bipolar depression [29].”
MethodSelf-citationExercise in bipolar patients: A systematic review
Melo, M. C. A., Daher, E. D. F., Albuquerque, S. G. C., & de Bruin, V. M. S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.004 · Cited by 135
Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy
Mayo-Wilson, E., Li, T., Fusco, N., Bertizzolo, L., Canner, J. K., Cowley, T., Doshi, P., Ehmsen, J., Gresham, G., Guo, N., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.07.014 · Cited by 108
Self-citation
Metadata
- Authors
- Kendall, T., Morriss, R., Mayo-Wilson, E., Marcus, E., & on behalf of the Guideline Development Group
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-09-25
- Volume
- 349
- Issue
- sep25 5
- Pages
- g5673-g5673
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2118761224
- Cited by
- 112
- References
- 2
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment and management of bipolar disorder: summary of updated NICE guidance. https://app.cochat.ai/papers/10.1136/bmj.g5673
- The paper
- Kendall, T., Morriss, R., Mayo-Wilson, E., Marcus, E., & on behalf of the Guideline Development Group. (2014). Assessment and management of bipolar disorder: summary of updated NICE guidance. BMJ. https://doi.org/10.1136/bmj.g5673
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.